Dr Reddys Laboratories

BSE : 500124 | NSE : DRREDDY
Industry : Pharmaceuticals | ISIN : INE089A01023 | FreeFloat : 70.65% | FnO : Yes | LotSize : 125
Intellectual Capital (IC)48,429.19
Net Worth (NW)22,027.30
Intrinsic Worth (IW)70,456.49
Market Cap (MC)70,565.22
Economic Value Added573.74
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)68.74%
IC Gross Margin (EBITDA/IC)14.43%
IC Net Margin (NPT/IC)8.45%
Knowledge Turnover (Sales/IC)0.52
Market to Intrinsic Value (MC/IW)1.00
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 4,231.02Rs. 4,237.55
20 Mar 2023 ---- Rs. 4,439.45
3.30     0.07%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 4,401.58BuyStrong Buy
KB > 50% : Yes50 DMA : Rs. 4,390.65
0 < M2IV < 1 : NoVol-Price trend : Rising
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
4448.90
4522.50
1033.30
759.20
736.20
781.10
654.80
Jun-20
C
4426.50
4513.60
1216.10
923.80
900.50
594.60
672.80
Sep-20
C
4910.90
4962.10
1214.60
898.10
872.90
771.80
783.80
Dec-20
C
4941.90
5012.40
624.90
313.70
294.90
27.90
120.80
Mar-21
C
4768.20
4850.80
1153.70
844.90
815.20
557.30
554.30
Jun-21
C
4945.10
5053.00
859.00
575.10
555.80
380.40
390.90
Sep-21
C
5786.90
5992.40
1590.00
1295.90
1272.50
995.80
974.40
Dec-21
C
5338.30
5394.10
1290.00
995.80
974.20
709.30
709.80
Mar-22
C
5474.90
5596.80
583.40
290.40
258.90
97.00
143.90
Jun-22
C
5232.90
6086.80
1804.50
1502.70
1468.00
1189.00
1032.30
Sep-22
C
6331.80
6372.60
1953.70
1644.50
1613.60
1114.20
1063.30
Dec-22
C
6789.80
6848.50
2003.20
1679.50
1637.70
1243.90
1424.30
* C - Consolidated, S - Standalone